Article Versions Notes

Casiraghi A, Gennari CG, Musazzi UM, Ortenzi MA, Bordignon S, Minghetti P. Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211”. Pharmaceutics. 2020; 12(9):822. https://doi.org/10.3390/pharmaceutics12090822

Casiraghi, Antonella, Chiara Grazia Gennari, Umberto Maria Musazzi, Marco Aldo Ortenzi, Susanna Bordignon, and Paola Minghetti. 2020. "Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211”" Pharmaceutics 12, no. 9: 822. https://doi.org/10.3390/pharmaceutics12090822

Casiraghi, A., Gennari, C. G., Musazzi, U. M., Ortenzi, M. A., Bordignon, S., & Minghetti, P. (2020). Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211”. Pharmaceutics, 12(9), 822. https://doi.org/10.3390/pharmaceutics12090822